VIP Dx is pleased to announce the availability, beginning Monday, August 23, 2010, of the WPI licensed serology test to detect antibodies to Human Gamma Retroviruses that include XMRV and its variants human MLV-related viruses.
Dr. Vincent Lombardi, the primary investigator and first author on paper that appeared in the 8 October 2009 issue of “Science”, is the Director of Operations for the licensing and development of the XAND test assays used by VIP Dx for the detection of XMRV. To download a copy of the paper by Dr. Lombardi et al, “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome” please go to www.sciencexpress.org. VIP Dx has licensed the same technology used in the research of the XMRV virus to develop their XAND (XMRV associated neurological disease) testing.
ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling